文献速递肝病消化道肿瘤与早癌消化内镜

肝硬化患者肝癌筛查中超声质量的动态变化

Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-06-10

重复检查时超声质量可变化,部分患者受限改善或恶化。

要点

  • 肥胖及酒精性或非酒精性脂肪性肝病肝硬化与受限相关。
  • 超声质量在重复检查间可变化,部分受限患者可改善。

核心结论

  • 近1/5肝硬化患者超声对HCC结节的可视化存在中重度受限,尤其在肥胖或酒精性/非酒精性脂肪性肝病肝硬化患者中。
  • 超声质量在两次检查间可发生变化,包括许多受限患者的改善。

研究设计与样本

  • 回顾性队列研究,纳入2016年7月至2019年7月在2个大型健康系统接受超声检查的肝硬化患者,共2053例。

主要发现

  • 2053例中,1685例(82.1%)可视化评分为A,262例(12.8%)为B,106例(5.2%)为C。
  • 可视化受限与酒精相关或非酒精性脂肪性肝病肝硬化及II-III级肥胖相关。
  • 1546例有多次超声的患者中,1129例(73.0%)随访评分不变(1046例A,60例B,23例C)。
  • 基线评分A的1301例中,255例(19.6%)重复检查时出现受限(230例B,25例C)。
  • 基线受限的245例中,130例(53.1%)重复检查时可视化良好。

临床怎么用

  • 对肥胖或酒精性/非酒精性脂肪性肝病肝硬化患者,应关注超声可视化质量,必要时考虑替代筛查手段。
  • 超声质量可动态变化,重复检查可能改善可视化,避免仅凭一次受限结果终止筛查。

局限性

  • 回顾性研究设计。
  • 仅纳入2个健康系统,外推性受限。
  • 未报告HCC检出率等临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Identifying patients in whom ultrasound may be inadequate to exclude the presence of hepatocellular carcinoma (HCC) can inform interventions to improve screening effectiveness. We aimed to characterize correlates of suboptimal ultrasound quality and changes in ultrasound quality over time in patients with cirrhosis undergoing HCC screening. METHODS: We performed a retrospective cohort study of patients with cirrhosis who underwent ultrasound examination at 2 large health systems between July 2016 and July 2019. Exam adequacy was graded by radiologists using the LI-RADS Visualization Score (A, B, C); we evaluated changes in visualization over time among patients with >1 ultrasound exams. We performed multivariable logistic regression to identify characteristics associated with limited ultrasound visualization (scores B or C). RESULTS: Of 2053 cirrhosis patients, 1685 (82.1%) had ultrasounds with score A, 262 (12.8%) had score B, and 106 (5.2%) had score C. Limited visualization was associated with alcohol-related or nonalcoholic fatty liver disease cirrhosis and presence of class II-III obesity. Among 1546 patients with >1 ultrasounds, 1129 (73.0%) had the same visualization score on follow-up (1046 score A, 60 score B, 23 score C). However, 255 (19.6%) of 1301 with score A at baseline had limited visualization when repeated (230 score B, 25 score C), and 130 (53.1%) of 245 patients with baseline limited visualization had good visualization when repeated. CONCLUSIONS: Nearly 1 in 5 patients with cirrhosis had moderately-severely limited ultrasound visualization for HCC nodules, particularly those with obesity or alcohol-related or nonalcoholic fatty liver disease cirrhosis. Ultrasound quality can change between exams, including improvement in many patients with limited visualization.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Schoenberger H, Chong N, Fetzer DT, et al. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021. PMID: 34119640. doi:10.1016/j.cgh.2021.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。